Cargando…
Surviving the Rookie Virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): The Immunopathology of a SARS-CoV2 Infection
Until July 29th, the number of confirmed coronavirus (COVID-19) cases worldwide has risen to over 16 million, within which 655 k deaths. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) emerges as the 11th global pandemic disease, showing the highest infectivity and lowest infection fatal...
Autores principales: | Tsai, Sheng Feng, Lu, Kang-Yun, Chuang, Hong-Meng, Liu, Ching-Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044562/ https://www.ncbi.nlm.nih.gov/pubmed/33840257 http://dx.doi.org/10.1177/0963689721993769 |
Ejemplares similares
-
Tissue immunity to SARS‐CoV‐2: Role in protection and immunopathology
por: Rybkina, Ksenia, et al.
Publicado: (2022) -
Reviewing immunopathology characteristics of SARS-CoV-2 for cancer entwisted with SARS-CoV-2
por: Li, Hongyan, et al.
Publicado: (2021) -
Pharmacotherapeutics of SARS-CoV-2 Infections
por: Kevadiya, Bhavesh D., et al.
Publicado: (2021) -
IL-6: Relevance for immunopathology of SARS-CoV-2
por: Gubernatorova, E.O., et al.
Publicado: (2020) -
Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)